Escherichia coli EDA is a novel fusion expression partner to improve solubility of aggregation-prone heterologous proteins

2015 ◽  
Vol 194 ◽  
pp. 39-47 ◽  
Author(s):  
Yoon-Sik Kang ◽  
Jong-Am Song ◽  
Kyung-Yeon Han ◽  
Jeewon Lee
2011 ◽  
Vol 49 (2) ◽  
pp. 124-130 ◽  
Author(s):  
Jong-Am Song ◽  
Dae-Sung Lee ◽  
Jin-Seung Park ◽  
Kyung-Yeon Han ◽  
Jeewon Lee

2008 ◽  
Vol 8 (1) ◽  
pp. 15 ◽  
Author(s):  
Jin-Seung Park ◽  
Kyung-Yeon Han ◽  
Jong-Ho Lee ◽  
Jong-Am Song ◽  
Keum-Young Ahn ◽  
...  

1998 ◽  
Vol 64 (12) ◽  
pp. 4862-4869 ◽  
Author(s):  
Jörg F. Rippmann ◽  
Michaela Klein ◽  
Christian Hoischen ◽  
Bodo Brocks ◽  
Wolfgang J. Rettig ◽  
...  

ABSTRACT Recently it has been demonstrated that L-form cells ofProteus mirabilis (L VI), which lack a periplasmic compartment, can be efficiently used in the production and secretion of heterologous proteins. In search of novel expression systems for recombinant antibodies, we compared levels of single-chain variable-fragment (scFv) production in Escherichia coliJM109 and P. mirabilis L VI, which express four distinct scFvs of potential clinical interest that show differences in levels of expression and in their tendencies to form aggregates upon periplasmic expression. Production of all analyzed scFvs in E. coli was limited by the severe toxic effect of the heterologous product as indicated by inhibition of culture growth and the formation of insoluble aggregates in the periplasmic space, limiting the yield of active product. In contrast, the L-form cells exhibited nearly unlimited growth under the tested production conditions for all scFvs examined. Moreover, expression experiments with P. mirabilis L VI led to scFv concentrations in the range of 40 to 200 mg per liter of culture medium (corresponding to volume yields 33- to 160-fold higher than those with E. coli JM109), depending on the expressed antibody. In a translocation inhibition experiment the secretion of the scFv constructs was shown to be an active transport coupled to the signal cleavage. We suppose that this direct release of the newly synthesized product into a large volume of the growth medium favors folding into the native active structure. The limited aggregation of scFv observed in the P. mirabilis L VI supernatant (occurring in a first-order-kinetics manner) was found to be due to intrinsic features of the scFv and not related to the expression process of the host cells. The P. mirabilis L VI supernatant was found to be advantageous for scFv purification. A two-step chromatography procedure led to homogeneous scFv with high antigen binding activity as revealed from binding experiments with eukaryotic cells.


2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Cheng Cheng ◽  
Shanshan Wu ◽  
Lupeng Cui ◽  
Yulu Wu ◽  
Tianyue Jiang ◽  
...  

1998 ◽  
Vol 64 (12) ◽  
pp. 4891-4896 ◽  
Author(s):  
Ji Qiu ◽  
James R. Swartz ◽  
George Georgiou

ABSTRACT The formation of native disulfide bonds in complex eukaryotic proteins expressed in Escherichia coli is extremely inefficient. Tissue plasminogen activator (tPA) is a very important thrombolytic agent with 17 disulfides, and despite numerous attempts, its expression in an active form in bacteria has not been reported. To achieve the production of active tPA in E. coli, we have investigated the effect of cooverexpressing native (DsbA and DsbC) or heterologous (rat and yeast protein disulfide isomerases) cysteine oxidoreductases in the bacterial periplasm. Coexpression of DsbC, an enzyme which catalyzes disulfide bond isomerization in the periplasm, was found to dramatically increase the formation of active tPA both in shake flasks and in fermentors. The active protein was purified with an overall yield of 25% by using three affinity steps with, in sequence, lysine-Sepharose, immobilized Erythrina caffra inhibitor, and Zn-Sepharose resins. After purification, approximately 180 μg of tPA with a specific activity nearly identical to that of the authentic protein can be obtained per liter of culture in a high-cell-density fermentation. Thus, heterologous proteins as complex as tPA may be produced in an active form in bacteria in amounts suitable for structure-function studies. In addition, these results suggest the feasibility of commercial production of extremely complex proteins inE. coli without the need for in vitro refolding.


2010 ◽  
Vol 62 (1) ◽  
pp. 296-300 ◽  
Author(s):  
Jian Feng Li ◽  
Jie Zhang ◽  
Zhen Zhang ◽  
Chun Tao Kang ◽  
Shuang Quan Zhang

2011 ◽  
Vol 109 (2) ◽  
pp. 325-335 ◽  
Author(s):  
Jong-Am Song ◽  
Dae-Sung Lee ◽  
Jin-Seung Park ◽  
Kyung-Yeon Han ◽  
Jeewon Lee

1998 ◽  
Vol 64 (5) ◽  
pp. 1589-1593 ◽  
Author(s):  
Michael J. Weickert ◽  
Izydor Apostol

ABSTRACT Coexpression of di-α-globin and β-globin in Escherichia coli in the presence of exogenous heme yielded high levels of soluble, functional recombinant human hemoglobin (rHb1.1). High-level expression of rHb1.1 provides a good model for measuring mistranslation in heterologous proteins. rHb1.1 does not contain isoleucine; therefore, any isoleucine present could be attributed to mistranslation, most likely mistranslation of one or more of the 200 codons that differ from an isoleucine codon by 1 bp. Sensitive amino acid analysis of highly purified rHb1.1 typically revealed ≤0.2 mol of isoleucine per mol of hemoglobin. This corresponds to a translation error rate of ≤0.001, which is not different from typical translation error rates found for E. coli proteins. Two different expression systems that resulted in accumulation of globin proteins to levels equivalent to ∼20% of the level of E. colisoluble proteins also resulted in equivalent translational fidelity.


2007 ◽  
Vol 20 (11) ◽  
pp. 543-549 ◽  
Author(s):  
K.-Y. Han ◽  
J.-A. Song ◽  
K.-Y. Ahn ◽  
J.-S. Park ◽  
H.-S. Seo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document